Cargando…
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
Activated protein C (APC) is a naturally occurring anticoagulant that interacts with factor V and VIII to inhibit the clotting cascade. The prevalence of APC resistance among Korean patients with deep vein thrombosis is ill defined. The aim of the present study was to investigate the prevalence of A...
Autores principales: | Kim, T. W., Kim, W. K., Lee, J. H., Kim, S. B., Kim, S. W., Suh, C., Lee, K. H., Lee, J. S., Seo, E. J., Chi, H. S., Kim, S. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054550/ https://www.ncbi.nlm.nih.gov/pubmed/9886165 |
Ejemplares similares
-
Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
por: Song, J., et al.
Publicado: (2000) -
The prevalence of Factor V Leiden (Arg506Gln) mutation in King Khalid University Hospital patients, 2017–2019
por: Al-Otaiby, Maram, et al.
Publicado: (2021) -
Current Trends in the Management of Acute Deep Vein Thrombosis among Korean Vascular Surgeons
por: Kim, Kyeong-Sik, et al.
Publicado: (2014) -
Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity
por: Fernández-Higuero, J. A., et al.
Publicado: (2015) -
Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines
por: Min, Seung-Kee, et al.
Publicado: (2016)